Exact Mass: 527.182303
Exact Mass Matches: 527.182303
Found 81 metabolites which its exact mass value is equals to given mass value 527.182303
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Daunorubicin
C27H29NO10 (527.1791374000001)
Daunorubicin is only found in individuals that have used or taken this drug. It is a very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms. [PubChem]Daunorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Daunorubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors KEIO_ID D106
4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp
C20H33NO15 (527.1850108000001)
An O(4)-glycosyl-L-hydroxyproline that is cis-L-hydroxylproline glycosylated by a beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf moiety
Esorubicin
C27H29NO10 (527.1791374000001)
D000970 - Antineoplastic Agents
N-Demethylmenogaril
C27H29NO10 (527.1791374000001)
Cerubidin
C27H29NO10 (527.1791374000001)
Pirozadil
C27H29NO10 (527.1791374000001)
(2,6-epoxy-1,2alpha,3beta,4alpha,5alpha-pentahydroxy)hexane-(1->6)-5,6-dihydrochelerythrine|maclekarpine D
C27H29NO10 (527.1791374000001)
Daunorubicin
C27H29NO10 (527.1791374000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent A natural product found in Actinomadura roseola. D004791 - Enzyme Inhibitors
Cys Phe Met Gln
C22H33N5O6S2 (527.1872158000001)
Cys Phe Gln Met
C22H33N5O6S2 (527.1872158000001)
Cys Gly Trp Tyr
Cys Gly Tyr Trp
Cys Met Phe Gln
C22H33N5O6S2 (527.1872158000001)
Cys Met Gln Phe
C22H33N5O6S2 (527.1872158000001)
Cys Gln Phe Met
C22H33N5O6S2 (527.1872158000001)
Cys Gln Met Phe
C22H33N5O6S2 (527.1872158000001)
Cys Trp Gly Tyr
Cys Trp Tyr Gly
Cys Tyr Gly Trp
Cys Tyr Trp Gly
Phe Cys Met Gln
C22H33N5O6S2 (527.1872158000001)
Phe Cys Gln Met
C22H33N5O6S2 (527.1872158000001)
Phe Met Cys Gln
C22H33N5O6S2 (527.1872158000001)
Phe Met Gln Cys
C22H33N5O6S2 (527.1872158000001)
Phe Gln Cys Met
C22H33N5O6S2 (527.1872158000001)
Phe Gln Met Cys
C22H33N5O6S2 (527.1872158000001)
Gly Cys Trp Tyr
Gly Cys Tyr Trp
Gly Trp Cys Tyr
Gly Trp Tyr Cys
Gly Tyr Cys Trp
Gly Tyr Trp Cys
Met Cys Phe Gln
C22H33N5O6S2 (527.1872158000001)
Met Cys Gln Phe
C22H33N5O6S2 (527.1872158000001)
Met Phe Cys Gln
C22H33N5O6S2 (527.1872158000001)
Met Phe Gln Cys
C22H33N5O6S2 (527.1872158000001)
Met Gln Cys Phe
C22H33N5O6S2 (527.1872158000001)
Met Gln Phe Cys
C22H33N5O6S2 (527.1872158000001)
Gln Cys Phe Met
C22H33N5O6S2 (527.1872158000001)
Gln Cys Met Phe
C22H33N5O6S2 (527.1872158000001)
Gln Phe Cys Met
C22H33N5O6S2 (527.1872158000001)
Gln Phe Met Cys
C22H33N5O6S2 (527.1872158000001)
Gln Met Cys Phe
C22H33N5O6S2 (527.1872158000001)
Gln Met Phe Cys
C22H33N5O6S2 (527.1872158000001)
Trp Cys Gly Tyr
Trp Cys Tyr Gly
Trp Gly Cys Tyr
Trp Gly Tyr Cys
Trp Tyr Cys Gly
Trp Tyr Gly Cys
Tyr Cys Gly Trp
Tyr Cys Trp Gly
Tyr Gly Cys Trp
Tyr Gly Trp Cys
Tyr Trp Cys Gly
Tyr Trp Gly Cys
Pirozadil
C27H29NO10 (527.1791374000001)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98151 - Niacin-based Antilipidemic Agent
Barnidipine
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
(7S,9S)-9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(7R,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(2R,4S)-4-[[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]methyl]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-2-carboxylic acid
C27H29NO10 (527.1791374000001)
9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp zwitterion
C20H33NO15 (527.1850108000001)
An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp.
10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(2s,3s,4r,5r)-2-[(s)-[(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl](hydroxy)methyl]oxane-2,3,4,5-tetrol
C27H29NO10 (527.1791374000001)
(8s,10s)-8-acetyl-10-{[(2r,4r,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(8s,10r)-10-{[(2s,4r,5r,6r)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
18-ethyl-9,10,20-trihydroxy-8-methoxy-7,20,23-trimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15-trione
C27H29NO10 (527.1791374000001)
(8s,10s)-10-{[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(5s,7r,8s,9r,10r,18r,20r)-18-ethyl-9,10,20-trihydroxy-8-methoxy-7,20,23-trimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15-trione
C27H29NO10 (527.1791374000001)
2-({17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}(hydroxy)methyl)oxane-2,3,4,5-tetrol
C27H29NO10 (527.1791374000001)